Under the MoU, the Asia Pacific Center of Excellence in Translational Science (AP CoE-TS) under Janssen AP R&D will work with OrigiMed in harnessing real-world data (RWD) for regulatory use and apply innovative applications to accelerate clinical development.

Pharmaceutical giant Johnson & Johnson has strengthened cooperation with Shanghai to further drive local innovative health-care solutions. Janssen (China) Research and Development Center of Johnson & Johnson (China) Investment Co...

The Lancet Regional Health – Europe publishes ‘real-world evidence’ from ALK-sponsored study confirming long-term benefits of allergy immunotherapy in allergic rhinitis and asthma

COPENHAGEN, Denmark, Dec. 1, 2021 /PRNewswire/ — ALK (ALKB: DC) (OMX: ALK B) (OMX: AKABY) (OMX: AKBLF) today announced that results from the REACT study, a large retrospective real-world study comprising more...